These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 29226859)

  • 21. Can preoperative CEA and CA19-9 serum concentrations suggest metastatic disease in colorectal cancer patients?
    Stojkovic Lalosevic M; Stankovic S; Stojkovic M; Markovic V; Dimitrijevic I; Lalosevic J; Petrovic J; Brankovic M; Pavlovic Markovic A; Krivokapic Z
    Hell J Nucl Med; 2017; 20(1):41-45. PubMed ID: 28315907
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic significance of interleukin-8 and CD163-positive cell-infiltration in tumor tissues in patients with oral squamous cell carcinoma.
    Fujita Y; Okamoto M; Goda H; Tano T; Nakashiro K; Sugita A; Fujita T; Koido S; Homma S; Kawakami Y; Hamakawa H
    PLoS One; 2014; 9(12):e110378. PubMed ID: 25461761
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum sAPRIL: a potential tumor-associated biomarker to colorectal cancer.
    Ding W; Wang J; Wang F; Wang G; Wu Q; Ju S; Cong H; Wang H
    Clin Biochem; 2013 Oct; 46(15):1590-4. PubMed ID: 23792260
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preoperative serum carcinoembryonic antigen, carbohydrate antigen19-9 and carbohydrate antigen 125 as prognostic factors for recurrence-free survival in colorectal cancer.
    Yang XQ; Chen C; Wang FB; Peng CW; Li Y
    Asian Pac J Cancer Prev; 2011; 12(5):1251-6. PubMed ID: 21875276
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum angiogenin as a potential biomarker for early detection of colorectal adenomas and colorectal cancer.
    Yu D; Sun J; Weng Y; Luo L; Sheng J; Xu Z
    Anticancer Drugs; 2021 Aug; 32(7):703-708. PubMed ID: 33661188
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of Serum Cytokeratines, Thymidine Kinase, and Growth Factors as Cancer Biomarkers in Colorectal Cancer.
    Karlíková M; Čurillová M; Pecen L; Karnos V; Karnos V; Topolčan O
    Anticancer Res; 2024 Jul; 44(7):3105-3113. PubMed ID: 38925804
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Soluble CD163 levels are elevated in cerebrospinal fluid and serum in people with Type 2 diabetes mellitus and are associated with impaired peripheral nerve function.
    Kallestrup M; Møller HJ; Tankisi H; Andersen H
    Diabet Med; 2015 Jan; 32(1):54-61. PubMed ID: 25156085
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum leucine-rich alpha-2-glycoprotein-1 with fucosylated triantennary N-glycan: a novel colorectal cancer marker.
    Shinozaki E; Tanabe K; Akiyoshi T; Tsuchida T; Miyazaki Y; Kojima N; Igarashi M; Ueno M; Suenaga M; Mizunuma N; Yamaguchi K; Nakayama K; Iijima S; Yamaguchi T
    BMC Cancer; 2018 Apr; 18(1):406. PubMed ID: 29642865
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum tetranectin is an independent prognostic marker in colorectal cancer and weakly correlated with plasma suPAR, plasma PAI-1 and serum CEA.
    Høgdall CK; Christensen IJ; Stephens RW; Sørensen S; Nørgaard-Pedersen B; Nielsen HJ
    APMIS; 2002 Sep; 110(9):630-8. PubMed ID: 12529016
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alu-based cell-free DNA: a potential complementary biomarker for diagnosis of colorectal cancer.
    Qi J; Qian C; Shi W; Wu X; Jing R; Zhang L; Wang Z; Ju S
    Clin Biochem; 2013 Jan; 46(1-2):64-9. PubMed ID: 22975639
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum macrophage-colony stimulating factor levels in colorectal cancer patients correlate with lymph node metastasis and poor prognosis.
    Mroczko B; Groblewska M; Wereszczyńska-Siemiatkowska U; Okulczyk B; Kedra B; Łaszewicz W; Dabrowski A; Szmitkowski M
    Clin Chim Acta; 2007 May; 380(1-2):208-12. PubMed ID: 17368603
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum TEM5 and TEM7 concentrations correlate with clinicopathologic features and poor prognosis of colorectal cancer patients.
    Pietrzyk Ł; Wdowiak P
    Adv Med Sci; 2019 Sep; 64(2):402-408. PubMed ID: 31352222
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Macrophage mannose receptor 1 and S100A9 were identified as serum diagnostic biomarkers for colorectal cancer through a label-free quantitative proteomic analysis.
    Fan NJ; Chen HM; Song W; Zhang ZY; Zhang MD; Feng LY; Gao CF
    Cancer Biomark; 2016; 16(2):235-43. PubMed ID: 26682511
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Investigation of cell free BIRC5 mRNA as a serum diagnostic and prognostic biomarker for colorectal cancer.
    Wang H; Zhang X; Wang L; Zheng G; Du L; Yang Y; Dong Z; Liu Y; Qu A; Wang C
    J Surg Oncol; 2014 May; 109(6):574-9. PubMed ID: 24338523
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Upregulation of kallikrein‑related peptidase 5 is associated with the malignant behavior of colorectal cancer.
    Wu Y; Chen Y; Li Q; Gong Y; Liu X; Bi L; Hu C
    Mol Med Rep; 2016 Sep; 14(3):2164-70. PubMed ID: 27430713
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of the numbers of CD163(+) cells in lesional skin and serum levels of soluble CD163 with disease progression of cutaneous T cell lymphoma.
    Sugaya M; Miyagaki T; Ohmatsu H; Suga H; Kai H; Kamata M; Fujita H; Asano Y; Tada Y; Kadono T; Okochi H; Sato S
    J Dermatol Sci; 2012 Oct; 68(1):45-51. PubMed ID: 22884782
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of serum Metadherin mRNA expression in the diagnosis and prediction of survival in patients with colorectal cancer.
    Abdel Ghafar MT; Gharib F; Abdel-Salam S; Elkhouly RA; Elshora A; Shalaby KH; El-Guindy D; El-Rashidy MA; Soliman NA; Abu-Elenin MM; Allam AA
    Mol Biol Rep; 2020 Apr; 47(4):2509-2519. PubMed ID: 32088817
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum Midkine is a clinical significant biomarker for colorectal cancer and associated with poor survival.
    Kemper M; Hentschel W; Graß JK; Stüben BO; Konczalla L; Rawnaq T; Ghadban T; Izbicki JR; Reeh M
    Cancer Med; 2020 Mar; 9(6):2010-2018. PubMed ID: 31984657
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of RCAS1 as a biomarker in diagnosing CRC and monitoring tumor recurrence and metastasis.
    Han SX; Wang J; Wang LJ; Jin GH; Ying X; He CC; Guo XJ; Zhang JY; Zhang Y; Zhu Q
    Tumour Biol; 2014 Jun; 35(6):6149-57. PubMed ID: 24652591
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multivariate analysis of the prognostic value of CEA and CA 19-9 serum levels in colorectal cancer.
    Reiter W; Stieber P; Reuter C; Nagel D; Lau-Werner U; Lamerz R
    Anticancer Res; 2000; 20(6D):5195-8. PubMed ID: 11326694
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.